We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+5.7%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$7.68B
AUM Growth
+$101M
(+1.3%)
Cap. Flow
-$193M
Cap. Flow
% of AUM
-2.51%
Top 10 Holdings %
Top 10 Hldgs %
17.01%
Holding
1,082
New
298
Increased
225
Reduced
230
Closed
304
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$123M |
| 2 |
CVS Health
CVS
|
+$75.5M |
| 3 |
VMW
VMware, Inc
VMW
|
+$62.2M |
| 4 |
Coca-Cola Europacific Partners
CCEP
|
+$51.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$50.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$97.3M |
| 2 |
AGN
Allergan Inc
AGN
|
+$79.1M |
| 3 |
Micron Technology
MU
|
+$67M |
| 4 |
HP
HPQ
|
+$65.4M |
| 5 |
Baxter International
BAX
|
+$55.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.38% |
| 2 | Financials | 13.7% |
| 3 | Communication Services | 11.26% |
| 4 | Technology | 9.89% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EJ
351
DELISTED
E HOUSE (CHINA) HOLDINGS LIMITED
EJ
| $4.2M | 0.05% |
774,020
+175,448
| +29% | +$1.2M |
|
352
Regal Rexnord
RRX
$14.2B
| $4.11M | 0.05% |
+51,401
| New | +$3.85M |
|
|
LM
353
DELISTED
Legg Mason, Inc.
LM
| $4.03M | 0.05% |
73,066
+66,220
| +967% | +$3.72M |
|
354
Valero Energy
VLO
$89.8B
| $4.03M | 0.05% |
63,380
+10,711
| +20% | +$598K |
|
355
NXP Semiconductors
NXPI
$68B
| $4.02M | 0.05% |
40,079
-1,023
| -2% | -$90.1K |
|
356
T. Rowe Price
TROW
$25B
| $4.01M | 0.05% |
+49,574
| New | +$4.08M |
|
|
WNR
357
DELISTED
Western Refining Inc
WNR
| $3.94M | 0.05% |
79,797
+52,429
| +192% | +$2.19M |
|
358
Petrobras
PBR
$121B
| $3.93M | 0.05% |
+653,948
| New | +$4.17M |
|
|
SLCA
359
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $3.92M | 0.05% |
+110,095
| New | +$3.22M |
|
360
CDW
CDW
$17.1B
| $3.92M | 0.05% |
105,204
-380,947
| -78% | -$13.9M |
|
361
Magnite
MGNI
$2.65B
| $3.92M | 0.05% |
+218,504
| New | +$3.68M |
|
362
Chegg
CHGG
$108M
| $3.91M | 0.05% |
+491,847
| New | +$3.65M |
|
363
Puma Biotechnology
PBYI
$406M
| $3.9M | 0.05% |
+16,513
| New | +$3.53M |
|
|
IM
364
DELISTED
Ingram Micro
IM
| $3.9M | 0.05% |
+155,230
| New | +$3.95M |
|
365
Salesforce
CRM
$134B
| $3.88M | 0.05% |
58,043
+15,783
| +37% | +$979K |
|
366
Corning
GLW
$126B
| $3.82M | 0.05% |
168,488
+135,177
| +406% | +$3.21M |
|
367
Enanta Pharmaceuticals
ENTA
$372M
| $3.78M | 0.05% |
123,457
-71,271
| -37% | -$2.77M |
|
368
Marvell Technology
MRVL
$174B
| $3.78M | 0.05% |
256,856
-573,807
| -69% | -$9.07M |
|
369
Blackrock
BLK
$164B
| $3.72M | 0.05% |
+10,160
| New | +$3.68M |
|
370
Rithm Capital
RITM
$5.09B
| $3.69M | 0.05% |
+245,424
| New | +$3.39M |
|
|
KATE
371
DELISTED
Kate Spade & Company
KATE
| $3.66M | 0.05% |
109,553
-12,847
| -10% | -$407K |
|
372
Bread Financial
BFH
$4.21B
| $3.61M | 0.05% |
15,279
+3,984
| +35% | +$910K |
|
|
GLOG
373
DELISTED
GASLOG LTD
GLOG
| $3.61M | 0.05% |
185,876
-40,846
| -18% | -$767K |
|
|
EMC
374
DELISTED
EMC CORPORATION
EMC
| $3.61M | 0.05% |
141,107
-113,036
| -44% | -$3.11M |
|
375
TriNet
TNET
$2.84B
| $3.6M | 0.05% |
102,067
+85,674
| +523% | +$2.95M |
|
Similar funds
Marshall Wace's Q1 2015 Portfolio in Review
As of Q1 2015, Marshall Wace held 1,082 positions worth $7.68B, up 1.3% from $7.57B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2015 filing shows 298 new, 225 increased, 230 reduced and 304 closed positions. Its largest new stake was Viatris: 845,509 shares worth $50.2M. The largest sale was T-Mobile US, an estimated $97.3M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 18% a quarter earlier, followed by Financials and Communication Services.
- Marshall Wace's largest Q1 2015 buy was Viatris: 845,509 shares worth $50.2M.
- Marshall Wace added most to Allergan plc in Q1 2015, an estimated $123M increase.
- Marshall Wace's biggest Q1 2015 reduction was T-Mobile US, cutting an estimated $97.3M.
- Marshall Wace fully exited Allergan Inc in Q1 2015, selling an estimated $79.1M.
- Marshall Wace's ten largest holdings make up 17% of its $7.68B portfolio in Q1 2015.
- Marshall Wace opened 298 new positions and closed 304 in Q1 2015.
- Marshall Wace's portfolio value rose 1.3% quarter-over-quarter to $7.68B.
Based on Marshall Wace's 13F filing for Q1 2015, filed 11 May 2015.